• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

Introduction to 4,7-Dimethyl-1,3-benzothiazol-2-amine (CAS No. 78584-08-4) and Its Emerging Applications in Chemical Biology

4,7-Dimethyl-1,3-benzothiazol-2-amine, identified by the chemical compound identifier CAS No. 78584-08-4, is a heterocyclic organic molecule that has garnered significant attention in the field of chemical biology due to its unique structural and pharmacological properties. This compound belongs to the benzothiazole family, a class of scaffolds widely recognized for their biological activity and versatility in drug design. The presence of nitrogen and sulfur atoms in its core structure imparts distinctive electronic and steric characteristics, making it a valuable building block for the development of novel therapeutic agents.

The benzothiazole ring system is a privileged motif in medicinal chemistry, exhibiting a broad spectrum of biological activities ranging from antimicrobial and anti-inflammatory effects to anticancer and antiviral properties. The specific substitution pattern in 4,7-Dimethyl-1,3-benzothiazol-2-amine enhances its potential as a pharmacophore, enabling interactions with various biological targets. Recent studies have highlighted its role in modulating enzyme activity and receptor binding, particularly in the context of neurological disorders and metabolic diseases.

In the realm of drug discovery, 4,7-Dimethyl-1,3-benzothiazol-2-amine has been explored as a precursor for synthesizing more complex derivatives with enhanced bioavailability and target specificity. Its molecular framework allows for facile functionalization at multiple positions, enabling the creation of libraries of compounds for high-throughput screening. Advanced computational methods, including molecular docking and quantum mechanical calculations, have been employed to predict the binding affinity of this compound to proteins such as kinases and transcription factors, which are pivotal in disease pathogenesis.

One of the most compelling aspects of 4,7-Dimethyl-1,3-benzothiazol-2-amine is its potential in addressing unmet medical needs. Emerging research indicates that derivatives of this compound may exhibit neuroprotective effects by inhibiting oxidative stress and neuroinflammation. These properties are particularly relevant in the context of neurodegenerative diseases such as Alzheimer's and Parkinson's disease, where modulation of neuronal survival pathways is crucial. Preclinical studies have demonstrated promising results in animal models, suggesting that further investigation could lead to the development of novel therapeutics.

The synthesis of 4,7-Dimethyl-1,3-benzothiazol-2-amine involves multi-step organic reactions that highlight its synthetic accessibility while maintaining high purity standards. Modern synthetic techniques, such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been optimized to produce this compound efficiently on both laboratory and industrial scales. This accessibility is critical for pharmaceutical applications, where scalability and cost-effectiveness are key considerations.

The pharmacokinetic profile of 4,7-Dimethyl-1,3-benzothiazol-2-amine is another area of active investigation. Studies have focused on understanding its absorption, distribution, metabolism, and excretion (ADME) properties to ensure optimal therapeutic efficacy. Advances in metabolomics have revealed insights into how this compound is processed within the body, providing valuable data for designing prodrugs or analogs with improved pharmacokinetic profiles.

Recent breakthroughs in biotechnology have enabled the use of 4,7-Dimethyl-1,3-benzothiazol-2-amine as a scaffold for developing targeted therapies. By integrating it with nanoparticles or biologics such as monoclonal antibodies, researchers aim to enhance drug delivery systems for precision medicine. These innovations hold promise for treating localized diseases while minimizing systemic side effects.

The environmental impact of synthesizing and utilizing 4,7-Dimethyl-1,3-benzothiazol-2-amine is also a consideration in modern research. Green chemistry principles have been applied to develop more sustainable synthetic routes that reduce waste and energy consumption. For instance, solvent-free reactions and microwave-assisted synthesis have been explored as alternatives to traditional methods.

In conclusion,4,7-Dimethyl-1，3-benzothiazol - 2 - amine (CAS No . 78584 - 08 - 4) represents a significant advancement in chemical biology with far-reaching implications for drug discovery and therapeutic development . Its unique structural features , coupled with emerging research findings , position it as a cornerstone compound for future investigations . As scientific understanding continues to evolve , it will be exciting to witness how this molecule contributes to addressing some of humanity's most pressing health challenges .

• 79050-49-0(4,5-dimethyl-1,3-benzothiazol-2-amine)
• 14779-17-0(5-Methylbenzodthiazol-2-amine)
• 26278-83-1(6-Benzothiazolol,2-amino-4,7-dimethyl-)
• 53065-21-7(2-Benzothiazolamine, 4-methyl-, hydrobromide (1:1))
• 14779-18-1(7-methyl-1,3-benzothiazol-2-amine)
• 1477-42-5(4-methyl-1,3-benzothiazol-2-amine)
• 2536-91-6(6-methyl-1,3-benzothiazol-2-amine)
• 62194-24-5(2-Benzothiazolamine, N,4,7-trimethyl-)
• 29927-08-0(5,6-dimethyl-1,3-benzothiazol-2-amine)
• 64036-71-1(4,6-dimethyl-1,3-benzothiazol-2-amine)